SCHEMBL1381245

SCHEMBL1381245

C=C(C(N)=O)c1cccc(Br)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.66
C1S P09871 1/20 0.55
SMN1; SMN2 Q16637 4/20 0.51
HPGD P15428 2/20 0.49
GAA P10253 2/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
ALDH1A1 P00352 2/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
MAPT P10636 3/20 0.44
MAPK1 P28482 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9615921 0.86 FURIN (0.48) PARP1GAAL3MBTL1MAPTMEN1
SCHEMBL2581836 0.82 PARP1 (0.57) PARP1C1SSMN1; SMN2HPGDGAA
SCHEMBL163949 0.79 PARP1 (1.00) PARP1C1SSMN1; SMN2HPGDGAA
SCHEMBL16803128 0.79 PARP1 (1.00) PARP1C1SSMN1; SMN2HPGDGAA
SCHEMBL11346008 0.79 C1S (0.63) PARP1C1SSMN1; SMN2HPGDGAA
SCHEMBL28771843 0.79 PARP1 (0.53) PARP1C1SSMN1; SMN2HPGDGAA
SCHEMBL27934182 0.79 PARP1 (0.53) PARP1C1SSMN1; SMN2HPGDALDH1A1
SCHEMBL28216252 0.78 PBRM1 (0.55) PARP1SMN1; SMN2ALDH1A1LMNAPOLB
SCHEMBL1378986 0.78 PARP1 (0.64) PARP1GAAALDH1A1MAPTLMNA
Hydrochloric Acid SCHEMBL5319538 0.78 PARP1 (0.96) PARP1C1SSMN1; SMN2HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4828407-B2 2011-11-30 JP claimed
EP-1594869-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF Targacept, Inc. (US) 2005-11-16 EP claimed
WO-2004076449-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF TARGACEPT, INC. (US) 2004-09-10 WO claimed
CN-111072663-B 8-substituted styrylxanthine derivatives and uses thereof 广东东阳光药业有限公司 2021-10-01 CN disclosed
CN-111072663-A 8-substituted styrylxanthine derivatives and uses thereof 广东东阳光药业有限公司 2020-04-28 CN disclosed
EP-1594869-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF Targacept, Inc. (US) 2005-11-16 EP disclosed
WO-2004076449-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF TARGACEPT, INC. (US) 2004-09-10 WO disclosed